Target intelligence / Profile preview

Septin-6 (SEPT6)

Target
SEPT6
Molecular classification
GTPase, Cytoskeletal protein
01

Overview

Septin-6 is a filament-forming cytoskeletal GTPase that is essential for normal organization of both the actin and microtubule cytoskeleton, playing a critical role in cytokinesis (cell division), formation and maintenance of cellular architecture, and membrane organization. It assembles into higher-order structures—rings and filaments—along microtubule and actin fibers, typically as part of heteromeric complexes with other septins such as SEPT7 and SEPT2. SEPT6 participates in protein sorting during multivesicular body biogenesis and regulates traffic of membrane proteins, particularly in neurons where it is highly expressed and associates with dendritic development. Mutations, aberrant expression, or chromosomal translocations involving SEPT6 are implicated in certain cancers and neuropathies. Structural studies have elucidated its coiled-coil regions, relevant for filament assembly and interfilament bridging, reinforcing its functional complexity in cellular architecture.

Other names
SEPTIN6SEP2SEPT2KIAA0128MGC16619MGC20339septin 6
02

Mechanism of action

N/A (no drugs directly targeting Septin-6 listed; mechanism would likely involve inhibition or modulation of GTPase activity or cytoskeletal filament formation if a drug existed)

03

Biological functions

Cytoskeleton organizationCytokinesis (cell division)Membrane organizationRegulation of microtubule and actin filament stabilityProtein sorting during multivesicular body biogenesis
04

Disease associations

Cancer (especially due to involvement in pediatric acute myeloid leukemia via chromosomal translocation)Neurodegenerative disease (implicated indirectly via roles in Charcot-Marie-Tooth neuropathies)Viral replication (HCV)
05

Safety considerations

Potential safety concerns if targeting SEPTIN6 include impairment of cell division and cytoskeletal dynamics, which could result in toxicity in proliferative tissues or during developmentSpecific therapeutic challenges may include selectivity due to functional redundancy among septins
06

Biomarkers

SEPTIN6 expression may serve as a biomarker for certain leukemias (where chromosomal translocations occur)No broadly validated biomarkers for patient selection or efficacy monitoring based specifically on SEPTIN6 are reported in the search results

Beyond the preview

Go deeper on Septin-6 (SEPT6).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Septin-6 (SEPT6).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call